DOI QR코드

DOI QR Code

Tamoxifen Induces Apoptosis of Leishmania major Promastigotes in Vitro

  • Doroodgar, Masoud (School of Medicine, Shahid Beheshti University of Medical Sciences) ;
  • Delavari, Mahdi (Department of Medical Parasitology, School of Medicine, Kashan University of Medical Sciences) ;
  • Doroodgar, Moein (School of Medicine, Shahid Beheshti University of Medical Sciences) ;
  • Abbasi, Ali (Department of Medical Parasitology, School of Medicine, Kashan University of Medical Sciences) ;
  • Taherian, Ali Akbar (Department of Pathology and Histology, School of Medicine, Kashan University of Medical Sciences) ;
  • Doroodgar, Abbas (Department of Medical Parasitology, School of Medicine, Kashan University of Medical Sciences)
  • 투고 : 2015.03.31
  • 심사 : 2015.08.31
  • 발행 : 2016.02.29

초록

Tamoxifen is an antagonist of the estrogen receptor and currently used for the treatment of breast cancer. The current treatment of cutaneous leishmaniasis with pentavalent antimony compounds is not satisfactory. Therefore, in this study, due to its antileishmanial activity, effects of tamoxifen on the growth of promastigotes and amastigotes of Leishmania major Iranian strain were evaluated in vitro. Promastigotes and amastigotes were treated with different concentrations (1, 5, 10, 20, and $50{\mu}g/ml$) and time periods (24, 48, and 72 hr) of tamoxifen. After tamoxifen treatment, MTT assay (3-[4,5-dimethylthiazol-2-yl]-2,5 biphenyl tetrazolium bromide assay) was used to determine the percentage of live parasites and Graph Pad Prism software to calculate $IC_{50}$. Flow cytometry was applied to investigate the induction of tamoxifen-induced apoptosis in promastigotes. The half maximal inhibitory concentration ($IC_{50}$) of tamoxifen on promastigotes was $2.6{\mu}g/ml$ after 24 hr treatment. Flow cytometry analysis showed that tamoxifen induced early and late apoptosis in Leishmania promastigotes. While after 48 hr in control group the apoptosis was 2.0%, the $50{\mu}g/L$ concentration of tamoxifen increased it to 59.7%. Based on the in vitro antileishmanial effect, tamoxifen might be used for leishmaniasis treatment; however, further researches on in vivo effects of tamoxifen in animal models are needed.

키워드

참고문헌

  1. World Health Organization (WHO). Control of the leishmaniases. Report of a meeting of the WHO Expert Committee on the Control of Leishmaniases, Geneva, Switzerland, 22-26 March 2010. WHO Tech Rep Ser 949.
  2. Doroodgar A, Sayyah M, Doroodgar M, Mahbobi S, Nemetian M, Rafizadeh S, Rassi Y. Progressive increasing of cutaneous leishmaniasis in Kashan district, central of Iran. Asian Pac J Trop Dis 2012; 2: 260-263. https://doi.org/10.1016/S2222-1808(12)60057-7
  3. Desjeux P. Leishmaniasis: current situation and new perspectives. Comp Immunol Microbiol Infect Dis 2004; 27: 305-318. https://doi.org/10.1016/j.cimid.2004.03.004
  4. Croft SL, Coombs GH. Leishmaniasis-current chemotherapy and recent advances in the search for novel drugs. Trends Parasitol 2003; 19: 502-508. https://doi.org/10.1016/j.pt.2003.09.008
  5. Croft SL, Yardley V. Chemotherapy of leishmaniasis. Curr Pharm Des 2002; 8: 319-342. https://doi.org/10.2174/1381612023396258
  6. Doroodgar A, Arbabi M, Razavi MR, Mohebali M, Sadr F. Treatment of cutaneous leishmaniasis in murine model by hydro alcoholic essence of Artemisia sieberi. Iranian J Arthropod-Borne Dis 2008; 2: 42-47.
  7. Eissa MM, Amer EI, El Sawy SMF. Leishmania major: activity of tamoxifen against experimental cutaneous leishmaniasis. Exp Parasitol 2011; 128: 382-390. https://doi.org/10.1016/j.exppara.2011.05.009
  8. Jordan VC. Tamoxifen: a most unlikely pioneering medicine. Nat Rev Drug Discov 2003; 2: 205-513. https://doi.org/10.1038/nrd1031
  9. Beggs WH. Drug protonation and pH in relation to the lethal action of tamoxifen on Candida albicans. Antimicrob Chemother J 1996; 37: 841-842. https://doi.org/10.1093/jac/37.4.841
  10. Drutz DJ, Huppert M, Sun SH. Human sex hormones stimulate the growth and maturation of Coccidioides immitis. Infect Immun 1981; 32: 897-907.
  11. Miguel DC, Zauli-Nascimento RC, Yokoyama-Yasunaka JK, Katz S, Barbieri CL, Uliana SR. Tamoxifen as a potential antileishmanial agent: efficacy in the treatment of Leishmania braziliensis and Leishmania chagasi infections. Antimicrob Chemother J 2009; 63: 365-368.
  12. Delavari M, Dalimi A, Ghaffarifar F, Sadraei J. In vitro study on cytotoxic effects of ZnO nanoparticles on promastigote and amastigote forms of Leishmania major (MRHO/IR/75/ER). Iranian J Parasitol 2014; 9: 6-13.
  13. Marufi Y, Ghaffarifar F, Dalimi A, Sharifi Z, Hassan ZM. Cantharidin-induced apoptosis in Leishmania major promastigotes and macrophages infected by Leishmania major amastigotes in-vitro. J Mazand Univ Med Sci J 2012; 22: 33-40 (in Persian).
  14. Rocha LG, Almeida JRGS, Macedo RO, Barbosa-Filho JM. A review of natural products with antileishmanial activity. Phytomedicine 2005; 12: 514-535. https://doi.org/10.1016/j.phymed.2003.10.006
  15. Nari Y, Chan-Ho L, Sun-Mee L. Protective effect of Aloe vera on polymicrobial sepsis in mice. Food Chem Toxicol 2009; 47: 1341-1348. https://doi.org/10.1016/j.fct.2009.03.013
  16. Dutta A, Mandal G, Mandal C, Chatterjee M. In vitro antileishmanial activity of Aloe vera leaf exudate: a potential herbal therapy in leishmaniasis. Glycoconj J 2007; 24: 81-86.
  17. Choi SW, Son BW, Son YS, Park YI, Lee SK, Chung MH. The wound-healing effect of a glycoprotein fraction isolated from Aloe vera. Br J Dermatol 2001; 145: 535-545. https://doi.org/10.1046/j.1365-2133.2001.04410.x
  18. Ebrahimi SP, Ghaffarifar F, Hassan ZM, Beheshti N. The effect of artemether-induced apoptosis in promastigotes of Leishmania major (MRHO/IR/75/ER) under in-vitro conditions. Modares J Med Sci Pathol 2012; 15: 1-10 (in Persian).
  19. Caroline P, Philippe ML, Christian B, Jaqueline B. Miltefosine induces apoptosis-like death in Leishmania donovani promastigotes. Antimicrob Agents Chemother 2004; 48: 852-859. https://doi.org/10.1128/AAC.48.3.852-859.2004
  20. Miguel DC, Yokoyama-Yasunaka JK, Uliana SR. Tamoxifen is effective in the treatment of Leishmania amazonensis infections in mice. PLoS Negl Trop Dis 2008; 2: 249. https://doi.org/10.1371/journal.pntd.0000249
  21. Trinconi CT, Reimao JQ, Yokoyama-Yasunaka JK, Miguel DC, Uliana SR. Combination therapy with tamoxifen and amphotericin B in experimental cutaneous leishmaniasis. Antimicrob Agents Chemother 2014; 58: 2608-2613. https://doi.org/10.1128/AAC.01315-13

피인용 문헌

  1. Library of Seleno-Compounds as Novel Agents against Leishmania Species vol.61, pp.6, 2017, https://doi.org/10.1128/aac.02546-16
  2. Caryocar coriaceum extracts exert leishmanicidal effect acting in promastigote forms by apoptosis-like mechanism and intracellular amastigotes by Nrf2/HO-1/ferritin dependent response and iron depleti vol.98, pp.None, 2018, https://doi.org/10.1016/j.biopha.2017.12.083
  3. Repurposing as a strategy for the discovery of new anti-leishmanials: the-state-of-the-art vol.145, pp.2, 2016, https://doi.org/10.1017/s0031182017000993
  4. Epidemiological Aspects of Cutaneous Leishmaniasis during 2009-2016 in Kashan City, Central Iran vol.56, pp.1, 2018, https://doi.org/10.3347/kjp.2018.56.1.21
  5. Tamoxifen Never Ceases to Amaze: New Findings on Non-Estrogen Receptor Molecular Targets and Mediated Effects vol.36, pp.4, 2018, https://doi.org/10.1080/07357907.2018.1453933
  6. Repurposing Estrogen Receptor Antagonists for the Treatment of Infectious Disease vol.9, pp.6, 2016, https://doi.org/10.1128/mbio.02272-18
  7. Study of Ethinyl Estradiol Activity Against Promastigotes, Axenic and Macrophage-Dwelling Amastigotes of Leishmania infantum by Using Atomic Force Microscopy and Methyl Thiazolyl Tetrazolium Methods vol.12, pp.8, 2016, https://doi.org/10.5812/jjm.90857
  8. In-vitro and In-vivo Antileishmanial Activity of a Compound Derived of Platinum, Oxaliplatin, against Leishmania Major vol.18, pp.4, 2019, https://doi.org/10.22037/ijpr.2019.15364.13046
  9. Selective Estrogen Receptor Modulators (SERMs): Mechanistic Insights Against Microbial Infections vol.20, pp.2, 2020, https://doi.org/10.2174/1566524019666191014112133
  10. Epidemiology, Associated Factors and Treatment Methods of Cutaneous Leishmaniasis Based on Previous Data from 2013 to 2018 in Ilam, Western Iran vol.65, pp.3, 2016, https://doi.org/10.2478/s11686-020-00198-y
  11. Diethyldithiocarbamate encapsulation reduces toxicity and promotes leishmanicidal effect through apoptosis-like mechanism in promastigote and ROS production by macrophage vol.28, pp.10, 2020, https://doi.org/10.1080/1061186x.2020.1783669
  12. The potential role and apoptotic profile of three medicinal plant extracts on Leishmania tropica by MTT assay, macrophage model and flow cytometry analysis vol.12, pp.None, 2016, https://doi.org/10.1016/j.parepi.2021.e00201
  13. Apoptosis-Like Cell Death in Leishmania major Treated with HESA-A: An Herbal Marine Compound vol.16, pp.3, 2016, https://doi.org/10.5812/jjnpp.99060
  14. Selective estrogen receptor modulators against Gram-positive and Gram-negative bacteria: an experimental study vol.16, pp.13, 2016, https://doi.org/10.2217/fmb-2020-0310
  15. Network-Based Approaches Reveal Potential Therapeutic Targets for Host-Directed Antileishmanial Therapy Driving Drug Repurposing vol.9, pp.2, 2016, https://doi.org/10.1128/spectrum.01018-21